During the past decade, Holmes Hosp / Univ of Cincinnati Med Ctr conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Holmes Hosp / Univ of Cincinnati Med Ctr" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 13 trials, followed by "Vertex Pharmaceuticals Incorporated" with 5 trials sponsored, "Glaxo Wellcome" with 4 trials sponsored, "Abbott" with 2 trials sponsored and "Health Decisions" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Holmes Hosp / Univ of Cincinnati Med Ctr" #1 collaborator was "Bristol-Myers Squibb" with 3 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Glaxo Wellcome" with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Holmes Hosp / Univ of Cincinnati Med Ctr" are "HIV Infections" (23 trials), "Cystic Fibrosis" (5 trials), "Meningitis, Cryptococcal" (2 trials), "Pneumonia, Pneumocystis Carinii" (2 trials) and "Cervical Ripening" (1 trials). Many other conditions were trialed in "Holmes Hosp / Univ of Cincinnati Med Ctr" in a lesser frequency.

Most popular intervention types in "Holmes Hosp / Univ of Cincinnati Med Ctr" are "Drug" (31 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (10 trials), "IVA" (5 trials), "Didanosine" (4 trials), "Lamivudine" (4 trials) and "Abacavir sulfate" (3 trials). Other intervention names were less common.

The vast majority of trials in "Holmes Hosp / Univ of Cincinnati Med Ctr" are 28 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Holmes Hosp / Univ of Cincinnati Med Ctr". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Holmes Hosp / Univ of Cincinnati Med Ctr, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Holmes Hosp / Univ of Cincinnati Med Ctr, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".